Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
EMBO J ; 39(2): e102924, 2020 01 15.
Article in English | MEDLINE | ID: mdl-31750958

ABSTRACT

Intrinsic genomic features of individual chromosomes can contribute to chromosome-specific aneuploidy. Centromeres are key elements for the maintenance of chromosome segregation fidelity via a specialized chromatin marked by CENP-A wrapped by repetitive DNA. These long stretches of repetitive DNA vary in length among human chromosomes. Using CENP-A genetic inactivation in human cells, we directly interrogate if differences in the centromere length reflect the heterogeneity of centromeric DNA-dependent features and whether this, in turn, affects the genesis of chromosome-specific aneuploidy. Using three distinct approaches, we show that mis-segregation rates vary among different chromosomes under conditions that compromise centromere function. Whole-genome sequencing and centromere mapping combined with cytogenetic analysis, small molecule inhibitors, and genetic manipulation revealed that inter-chromosomal heterogeneity of centromeric features, but not centromere length, influences chromosome segregation fidelity. We conclude that faithful chromosome segregation for most of human chromosomes is biased in favor of centromeres with high abundance of DNA-dependent centromeric components. These inter-chromosomal differences in centromere features can translate into non-random aneuploidy, a hallmark of cancer and genetic diseases.


Subject(s)
Aneuploidy , Centromere Protein A/metabolism , Centromere/metabolism , Chromatin/metabolism , Chromosomes, Human/genetics , DNA/metabolism , Cells, Cultured , Centromere/genetics , Centromere Protein A/genetics , Chromatin/genetics , Chromosome Segregation , DNA/genetics , Female , Humans , Male
2.
Cell Rep ; 23(11): 3366-3380, 2018 06 12.
Article in English | MEDLINE | ID: mdl-29898405

ABSTRACT

A common assumption is that human chromosomes carry equal chances of mis-segregation during compromised cell division. Human chromosomes vary in multiple parameters that might generate bias, but technological limitations have precluded a comprehensive analysis of chromosome-specific aneuploidy. Here, by imaging specific centromeres coupled with high-throughput single-cell analysis as well as single-cell sequencing, we show that aneuploidy occurs non-randomly following common treatments to elevate chromosome mis-segregation. Temporary spindle disruption leads to elevated mis-segregation and aneuploidy of a subset of chromosomes, particularly affecting chromosomes 1 and 2. Unexpectedly, we find that a period of mitotic delay weakens centromeric cohesion and promotes chromosome mis-segregation and that chromosomes 1 and 2 are particularly prone to suffer cohesion fatigue. Our findings demonstrate that inherent properties of individual chromosomes can bias chromosome mis-segregation and aneuploidy rates, with implications for studies on aneuploidy in human disease.


Subject(s)
Chromosome Segregation , Chromosomes, Human/metabolism , Anaphase , Aneuploidy , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line, Tumor , Chromosome Segregation/drug effects , Chromosomes, Human/genetics , Humans , In Situ Hybridization, Fluorescence , Kinetochores/metabolism , Nocodazole/pharmacology , Nuclear Proteins/antagonists & inhibitors , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Proto-Oncogene Proteins/antagonists & inhibitors , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Single-Cell Analysis
3.
Protein Eng Des Sel ; 30(5): 359-372, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28180900

ABSTRACT

Wnt signaling pathways are required for a wide variety of biological processes ranging from embryonic development to tissue repair and regeneration. Dickkopf-2 (DKK2) is classically defined as a canonical Wnt inhibitor, though it may play a role in activating non-canonical Wnt pathways in the context of endothelial network formation after acute injury. Here we report the discovery of a fusion partner for a DKK2 polypeptide that significantly improves the expression, biochemical properties and pharmacokinetics (PK) of the DKK2 polypeptide. Specifically, human serum albumin (HSA) was identified as a highly effective fusion partner. Substitution of selected amino acid residues in DKK2 designed to decrease heparan sulfate binding by HSA-DKK2 variants, further improved the PK properties of the molecule in rodents. The HSA-DKK2 variants were monomeric, as thermally stable as wild type, and active as measured by their ability to bind to and prevent phosphorylation of the Wnt coreceptor LRP6. Our engineering efforts resulted in potent long-lived variants of the canonical Wnt inhibitor DKK2, applicable for Wnt pathway manipulation either by systematic delivery or focused administration at sites of tissue injury.


Subject(s)
Intercellular Signaling Peptides and Proteins , Low Density Lipoprotein Receptor-Related Protein-6/antagonists & inhibitors , Protein Engineering , Recombinant Fusion Proteins , Serum Albumin , Wnt Proteins/antagonists & inhibitors , Wnt Signaling Pathway/drug effects , Animals , Humans , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/chemistry , Intercellular Signaling Peptides and Proteins/isolation & purification , Intercellular Signaling Peptides and Proteins/pharmacology , Mice , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/pharmacology , Serum Albumin/biosynthesis , Serum Albumin/chemistry , Serum Albumin/isolation & purification , Serum Albumin/pharmacology
4.
Cell Rep ; 14(3): 440-448, 2016 Jan 26.
Article in English | MEDLINE | ID: mdl-26774483

ABSTRACT

In animals, the protein kinase C (PKC) family has expanded into diversely regulated subgroups, including the Rho family-responsive PKN kinases. Here, we describe knockouts of all three mouse PKN isoforms and reveal that PKN2 loss results in lethality at embryonic day 10 (E10), with associated cardiovascular and morphogenetic defects. The cardiovascular phenotype was not recapitulated by conditional deletion of PKN2 in endothelial cells or the developing heart. In contrast, inducible systemic deletion of PKN2 after E7 provoked collapse of the embryonic mesoderm. Furthermore, mouse embryonic fibroblasts, which arise from the embryonic mesoderm, depend on PKN2 for proliferation and motility. These cellular defects are reflected in vivo as dependence on PKN2 for mesoderm proliferation and neural crest migration. We conclude that failure of the mesoderm to expand in the absence of PKN2 compromises cardiovascular integrity and development, resulting in lethality.


Subject(s)
Mesoderm/metabolism , Protein Kinase C/genetics , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line , Cell Movement/drug effects , Cell Proliferation/drug effects , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Embryonic Development/drug effects , Genes, Reporter , Heart/growth & development , Mesoderm/cytology , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron, Scanning , Myocardium/metabolism , Myocardium/pathology , Protein Kinase C/deficiency , Protein Kinase C/metabolism , Tamoxifen/analogs & derivatives , Tamoxifen/pharmacology
5.
Mult Scler ; 20(14): 1806-13, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25122475

ABSTRACT

Neurodegeneration in multiple sclerosis (MS) is related to inflammation and demyelination. In acute MS lesions and experimental autoimmune encephalomyelitis focal immune attacks damage axons by injuring axonal mitochondria. In progressive MS, however, axonal damage occurs in chronically demyelinated regions, myelinated regions and also at the active edge of slowly expanding chronic lesions. How axonal energy failure occurs in progressive MS is incompletely understood. Recent studies show that oligodendrocytes supply lactate to myelinated axons as a metabolic substrate for mitochondria to generate ATP, a process which will be altered upon demyelination. In addition, a number of studies have identified mitochondrial abnormalities within neuronal cell bodies in progressive MS, leading to a deficiency of mitochondrial respiratory chain complexes or enzymes. Here, we summarise the mitochondrial abnormalities evident within neurons and discuss how these grey matter mitochondrial abnormalities may increase the vulnerability of axons to degeneration in progressive MS. Although neuronal mitochondrial abnormalities will culminate in axonal degeneration, understanding the different contributions of mitochondria to the degeneration of myelinated and demyelinated axons is an important step towards identifying potential therapeutic targets for progressive MS.


Subject(s)
Axons/metabolism , Mitochondria/metabolism , Multiple Sclerosis, Chronic Progressive/metabolism , Gray Matter/metabolism , Humans , Multiple Sclerosis , Neurons/metabolism
6.
J Biochem ; 147(4): 601-9, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20147452

ABSTRACT

The activation of receptor tyrosine kinases (RTKs) is tightly regulated through a variety of mechanisms. Kinetic studies show that activation of c-Kit RTK occurs through an inter-molecular autophosphorylation. Phosphopeptide mapping of c-Kit reveals that 14-22 phosphates are added to each mol of wild-type (WT) c-Kit during the activation. Phosphorylation sites are found on the JM, kinase insert (KID), c-terminal domains and the activation loop (A-loop), but only the sites on the JM domain contribute to the kinase activation. The A-loop tyrosine (Y(823)) is not phosphorylated until very late in the activation (>90% completion), indicating that the A-loop phosphorylation is not required for c-Kit activation. A sunitinib-resistant mutant D816H that accelerates auto-activation by 184-fold shows no phosphorylation on the A-loop tyrosine after full activation. A loss-of-phosphorylation mutation Y823F remains fully competent in auto-activation. Similar to WT and D816H, the unactivated Y823F mutant binds sunitinib and imatinib with high affinity (K(D) = 5.9 nM). But unlike the WT and D816H where the activated enzymes lose the ability to bind the two drugs, activated Y823F binds the two inhibitors effectively. These observations suggest that the A-loop of activated Y823F remains flexible and can readily adopt unactivated conformations to accommodate DFG-out binders.


Subject(s)
Antineoplastic Agents/metabolism , Drug Resistance, Neoplasm , Enzyme Inhibitors/metabolism , Indoles/metabolism , Phosphotyrosine/physiology , Protein Interaction Domains and Motifs/physiology , Proto-Oncogene Proteins c-kit/metabolism , Pyrroles/metabolism , Amino Acid Substitution , Benzamides , Catalytic Domain , Enzyme Activation , Humans , Imatinib Mesylate , Kinetics , Microchemistry/methods , Models, Biological , Mutant Proteins/chemistry , Mutant Proteins/isolation & purification , Mutant Proteins/metabolism , Peptide Mapping , Phosphorylation , Piperazines/metabolism , Protein Binding , Proto-Oncogene Proteins c-kit/antagonists & inhibitors , Proto-Oncogene Proteins c-kit/chemistry , Proto-Oncogene Proteins c-kit/genetics , Pyrimidines/metabolism , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Sunitinib
7.
J Clin Ultrasound ; 38(6): 328-31, 2010 Jul.
Article in English | MEDLINE | ID: mdl-19902525

ABSTRACT

We report the case of dicephalic conjoined twins discovered incidentally on a routine ultrasound at 24 weeks of gestation. There were 2 heads and a neck that fused with 1 thorax, but the spines continued all the way to the coccyx. The spines were connected medially by a fused rib, and laterally, there were ribs that went around the thorax in a more normal fashion. Antenatal ultrasound images are supplemented by postnatal photographs and x-rays.


Subject(s)
Twins, Conjoined , Ultrasonography, Prenatal/methods , Abortion, Eugenic/methods , Adult , Cesarean Section , Female , Humans , Incidental Findings , Male
8.
Chem Commun (Camb) ; (22): 2338-40, 2006 Jun 14.
Article in English | MEDLINE | ID: mdl-16733572

ABSTRACT

Cytochrome c adsorbed to anionic nanoparticles is selectively proteolyzed by trypsin, providing a mechanism for the catalytic degradation of proteins.


Subject(s)
Cytochromes c/chemistry , Electrophoresis, Agar Gel/methods , Nanoparticles/chemistry , Trypsin/chemistry , Adsorption , Binding Sites , Catalysis , Sensitivity and Specificity , Surface Properties , Time Factors
9.
J Am Chem Soc ; 126(43): 13987-91, 2004 Nov 03.
Article in English | MEDLINE | ID: mdl-15506760

ABSTRACT

Positively charged trimethylammonium-functionalized mixed monolayer protected clusters (MMPCs) of different chain lengths (C(8) and C(11)) have been used to bind beta-galactosidase through complementary electrostatic interactions, resulting in complete enzyme inhibition. This inhibition can be reversed in vitro by intracellular concentrations of glutathione (GSH), the main thiol component of the cell. The restoration of activity depends on the chain length of the monolayer. The activity of enzyme bound to particles with C(8) monolayer was completely restored by intracellular concentrations (1-10 mM) of GSH; however, little or no release was observed at extracellular GSH concentrations. In contrast, no restoration was observed for enzyme bound to the C(11) particles at any of the concentrations studied. Taken together, these studies demonstrate that the GSH-mediated release of enzymes bound to MMPCs can be tuned through the structure of the monolayer, a significant tool for protein and drug delivery applications.


Subject(s)
Glutathione/pharmacology , Quaternary Ammonium Compounds/pharmacology , beta-Galactosidase/antagonists & inhibitors , beta-Galactosidase/metabolism , Electrophoresis, Agar Gel , Enzyme Activation , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Glutathione/chemistry , Glutathione/metabolism , Nanostructures , Quaternary Ammonium Compounds/chemistry , Quaternary Ammonium Compounds/metabolism
10.
J Ultrasound Med ; 23(10): 1361-7, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15448326

ABSTRACT

OBJECTIVES: To review sonographic findings that can mimic renal calculi. METHODS: We comment on a number of echoes that can mimic renal calculi. RESULTS: There are a number of sonographic renal artifacts, vascular and nonvascular, that may confound a correct diagnosis. CONCLUSIONS: Awareness of these potential artifacts will result in a more specific sonographic examination and will accurately guide the referring physician toward appropriate patient treatment. The importance of other imaging modalities is also emphasized to ensure that a correct diagnosis is obtained whenever the sonographic findings are inconclusive.


Subject(s)
Calcinosis/diagnostic imaging , Kidney Calculi/diagnostic imaging , Kidney Neoplasms/diagnostic imaging , Angiomyolipoma/diagnostic imaging , Diagnosis, Differential , Foreign Bodies/diagnostic imaging , Humans , Kidney Cortex/diagnostic imaging , Tomography, X-Ray Computed , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...